A randomized trial of antithrombin concentrate for treatment of heparin resistance Mathew R Williams, MD, Alyssa B D’Ambra, BA, James R Beck, Talia B.

Slides:

Advertisements

Similar presentations

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Advertisements

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

David W. Barbara, MD, William J. Mauermann, MD, James R

John Parker Gott, MD, William A Cooper, MD, Frank E Schmidt, MD, W

The Myocardial Protective Effects of a Moderate-Potassium Blood Cardioplegia in Pediatric Cardiac Surgery: A Randomized Controlled Trial Yang Liu, MD,

A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients Lena Lindholm,

International Participation in The Society of Thoracic Surgeons Adult Cardiac Surgery Database: From Institutional to National Oz M. Shapira, MD, Orit.

P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J

Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants Takaaki Suzuki, MD, Toyoki Fukuda, MD, Tsutomu Ito, MD,

James L Zellner, MD, Scott B Kribbs, BS, B

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Effect of perfusion flow rate on tissue oxygenation in newborn piglets during cardiopulmonary bypass Gregory Schears, MD, Steven E Schultz, MD, Jennifer.

Assessment of heparin anticoagulation: comparison of two commercially available methods Hanne I Flom-Halvorsen, PhD, Eivind Øvrum, MD, PhD, Michel Abdelnoor,

Steven R. Gundry, MD, Matthew A. Romano, MD, O

Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization Hiroshi Kumano, MD, PhD, Shigefumi Suehiro, MD, PhD, Koji.

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Thierry P Carrel, MD, Mike Schwanda, MD,

Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass–induced injury Maurice Beghetti, MD, Philip E Silkoff, Marlova Caramori, MD,

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all David Faraoni, MD,

Effect of Heparin Loading During Congenital Heart Operation on Thrombin Generation and Blood Loss Sophronia O Turner-Gomes, MB, ChB, Evan P Nitschmann,

Ricardo H Boks, BS, Lex A van Herwerden, MD, PhD, Johanna J

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass Elijah W. Muriithi,

Brain SPECT imaging and neuropsychological testing in coronary artery bypass patients R.Alan Hall, MD, David J Fordyce, PhD, Marie E Lee, MD, Brian Eisenberg,

David L. S. Morales, MD, Muhammad S. Khan, MD, Joseph W

Comparative effects of propofol versus fentanyl on cerebral oxygenation state during normothermic cardiopulmonary bypass and postoperative cognitive dysfunction

Heparin-induced thrombocytopenia and cardiac surgery

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD

Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model Hitoshi Suhara, MD, Yoshiki Sawa, MD, Motonobu Nishimura,

Effects of selectin–sialyl Lewisx blockade on mesenteric microvascular permeability associated with cardiopulmonary bypass Charles S. Cox, MD, Steven.

Kyle W. Riggs, MD, David L.S. Morales, MD

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Hypothermic Low-Flow Cardiopulmonary Bypass Impairs Pulmonary and Right Ventricular Function More Than Circulatory Arrest Jess M. Schultz, MD, Tara Karamlou,

Individualized heparin and protamine management in infants and children undergoing cardiac operations Massimiliano Codispoti, MD, Christopher A Ludlam,

C.Thomas Wass, David G Cable, Hartzell V Schaff, William L Lanier

Safety and efficacy of a heparin removal device: a prospective randomized preclinical outcomes study Joseph B Zwischenberger, MD, Weike Tao, MD, Donald.

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary.

Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass Nobuhiko Hayashida, MD, PhD, Hiroshi Tomoeda, MD, Takeshi Oda, MD,

No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits Christian Olsson, MD, Agneta Siegbahn, MD, PhD,

Stephanie B. Clayton, PharmD, Jeffrey R. Acsell, CCP, Arthur J

Inflammatory Mediators in Adults Undergoing Cardiopulmonary Bypass: Comparison of Centrifugal and Roller Pumps Saeed Ashraf, John Butler, Yi Tian, Dahlia.

Sune Damgaard, MD, PhD, Claus H. Nielsen, MD, PhD, Lars W

Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass Jeffrey M.

Effect of cardiopulmonary bypass on pulmonary gas exchange: a prospective randomized study Craig M Cox, Raimondo Ascione, MD, Alan M Cohen, Ian M Davies,

Neurocognitive Function and Cerebral Emboli: Randomized Study of On-Pump Versus Off-Pump Coronary Artery Bypass Surgery Reza Motallebzadeh, MRCS, J.

Cardiac surgery during pregnancy: pulsatile or nonpulsatile perfusion?

Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Gary E Hill, Robert P Diego, Alfred H Stammers, Suzanne M Huffman,

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Effect of Nitric Oxide Gas on Platelets During Open Heart Operations

Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.

Alternative technique of right-sided outflow cannula insertion for right ventricular support Todd M Dewey, MD, Jonathan M Chen, MD, Talia B Spanier,

Method and Value of Digital Recording of Operations for Congenital Heart Disease Mazyar Kanani, MRCS, Ergin Kocyildirim, MD, Gordon Cohen, MD, Kieran.

Fraser D. Rubens, MD, MS, Gilbert Lavalee, Marc A

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Aprotinin in deep hypothermic circulatory arrest

Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery William C Oliver, MD, David N Fass, PhD, Gregory A Nuttall,

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Did you like Terminator 3 better than Terminator 2

An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass

Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury Christine S Rinder, MD, Manuel Fontes, MD,

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Safety of low hematocrits during cardiopulmonary bypass

Y.John Gu, MD, PhD, Piet W. Boonstra, MD, PhD, Willem van Oeveren, PhD

A prospective randomized study of neurocognitive function and S-100 protein after antegrade or retrograde brain perfusion with hypothermic arrest for.

Thrombophilic Variables Do Not Increase the Generation or Procoagulant Activity of Thrombin During Cardiopulmonary Bypass Peter Raivio, MD, Jari Petäjä,

Presentation transcript:

A randomized trial of antithrombin concentrate for treatment of heparin resistance Mathew R Williams, MD, Alyssa B D’Ambra, BA, James R Beck, Talia B Spanier, MD, David L.S Morales, MD, David N Helman, MD, Mehmet C Oz, MD The Annals of Thoracic Surgery Volume 70, Issue 3, Pages 873-877 (September 2000) DOI: 10.1016/S0003-4975(00)01550-2

Fig 1 Antithrombin (AT) activity at baseline, 30 minutes after commencing cardiopulmonary bypass (CPB), and at termination of CPB. Both groups had similarly deficient AT activity at baseline but there was a significant rise in activity in the AT concentrate group at the two later time points (p = 0.007 and p = 0.009). (AT = antithrombin; CPB = cardiopulmonary bypass; ∗ denotes statistical significance.) The Annals of Thoracic Surgery 2000 70, 873-877DOI: (10.1016/S0003-4975(00)01550-2)